Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NBTX · against 458 other Healthcare companies of similar size
Ranked #431 of 459 · scores higher than 6% of peers · safety percentile 7
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)39 peers with a safety percentile of 0–9, including NBTX · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NBTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 436 reported | Not reported | 0.21× | — | — | 33% |
| BetaLower is better · 431 reported | 0.57 | 0.52 | 46% | 33% | |
| Current ratioHigher is better · 446 reported | 1.09× | 2.81× | 10% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 1.0B USD | 99 | 35 | |
| 427 | 965M EUR (≈$1.1B) | 8 | 37 | |
| 428 | 952M USD | 8 | 3 | |
| 429 | 12.1B CNY (≈$1.7B) | 8 | 15 | |
| 430 | 2.5B USD | 7 | 32 | |
| 431 | 1.5B USD | 7 | 32 | |
| 432 | 42.9B TWD (≈$1.3B) | 7 | 57 | |
| 433 | 1.2B USD | 7 | 36 | |
| 434 | 9.9B HKD (≈$1.3B) | 7 | 17 | |
| 435 | 1.2B USD | 6 | 3 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score